ストックスクリーナーアプリを入手
218.04
4.45%
-10.16
アフターアワーズ：
217.80
-0.24
-0.11%
前日終値:
$228.20
開ける：
$223
24時間の取引高:
10.82M
Relative Volume:
2.00
時価総額：
$385.18B
収益：
$58.33B
当期純損益:
$3.73B
株価収益率:
103.76
EPS:
2.1013
ネットキャッシュフロー:
$18.24B
1週間 パフォーマンス:
-4.36%
1か月 パフォーマンス:
-5.83%
6か月 パフォーマンス:
+11.76%
1年 パフォーマンス:
+6.95%
1日の値動き範囲:
$216.00
$223.87
1週間の範囲:
$216.00
$229.65
52週間の値動き範囲:
$163.81
$244.81
Abbvie Inc Stock (ABBV) Company Profile
ABBV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
218.04 | 403.13B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
LLY
Lilly Eli Co
|
862.86 | 757.06B | 59.42B | 18.41B | -50.20M | 20.22 |
|
JNJ
Johnson Johnson
|
188.87 | 455.48B | 92.15B | 25.12B | 20.46B | 10.36 |
|
NVS
Novartis Ag Adr
|
123.79 | 235.26B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
85.98 | 215.51B | 63.99B | 19.05B | 14.72B | 7.5596 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-14 | ダウングレード | Erste Group | Buy → Hold |
| 2025-10-01 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-09-17 | アップグレード | Berenberg | Hold → Buy |
| 2025-08-12 | 再開されました | Piper Sandler | Overweight |
| 2025-08-07 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-10 | 再開されました | BofA Securities | Neutral |
| 2024-12-05 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-11-04 | アップグレード | Argus | Hold → Buy |
| 2024-10-17 | 開始されました | Bernstein | Mkt Perform |
| 2024-06-05 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-05-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-01-29 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | ダウングレード | HSBC Securities | Buy → Hold |
| 2023-12-11 | アップグレード | Goldman | Neutral → Buy |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-10-30 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 再開されました | UBS | Neutral |
| 2023-09-29 | 開始されました | Raymond James | Outperform |
| 2023-07-25 | 開始されました | William Blair | Mkt Perform |
| 2023-07-14 | 開始されました | HSBC Securities | Buy |
| 2023-04-05 | ダウングレード | Argus | Buy → Hold |
| 2023-03-01 | 開始されました | Guggenheim | Buy |
| 2023-02-22 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | アップグレード | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | 開始されました | Credit Suisse | Outperform |
| 2022-11-08 | ダウングレード | Societe Generale | Buy → Hold |
| 2022-08-01 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | 開始されました | SVB Leerink | Underperform |
| 2022-05-06 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2022-02-28 | ダウングレード | UBS | Buy → Neutral |
| 2022-02-03 | 繰り返されました | BMO Capital Markets | Outperform |
| 2022-02-03 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-03 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-03 | 繰り返されました | Goldman | Neutral |
| 2022-01-13 | 開始されました | Redburn | Buy |
| 2022-01-12 | 繰り返されました | BMO Capital Markets | Outperform |
| 2021-12-09 | 再開されました | Wells Fargo | Overweight |
| 2021-11-23 | アップグレード | Societe Generale | Hold → Buy |
| 2021-07-27 | 再開されました | Truist | Buy |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2020-11-10 | 再開されました | Bernstein | Outperform |
| 2020-09-29 | 開始されました | Berenberg | Hold |
| 2020-06-23 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | アップグレード | Argus | Hold → Buy |
| 2020-05-18 | 再開されました | BofA/Merrill | Neutral |
| 2020-05-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-05-11 | 再開されました | Morgan Stanley | Overweight |
| 2020-04-20 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | ダウングレード | Societe Generale | Buy → Hold |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-02-06 | 開始されました | Mizuho | Buy |
| 2020-01-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | 繰り返されました | Cowen | Outperform |
| 2019-09-26 | アップグレード | Citigroup | Neutral → Buy |
| 2019-08-20 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | 開始されました | Goldman | Neutral |
| 2019-04-29 | アップグレード | BMO Capital Markets | Underperform → Market Perform |
すべてを表示
Abbvie Inc (ABBV) 最新ニュース
Reversal indicators forming on AbbVie Inc. stockEarnings Trend Report & Real-Time Buy Signal Alerts - newser.com
Can AbbVie Inc. stock retain market dominance2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
2 Magnificent Dividend Stocks to Buy and Hold Forever - The Motley Fool
State of Michigan Retirement System Buys 1,400 Shares of AbbVie Inc. $ABBV - MarketBeat
Nicholas Company Inc. Cuts Holdings in AbbVie Inc. $ABBV - MarketBeat
Tredje AP fonden Cuts Position in AbbVie Inc. $ABBV - MarketBeat
Triglav Investments D.O.O. Lowers Stake in AbbVie Inc. $ABBV - MarketBeat
C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Boosts Stock Position in AbbVie Inc. $ABBV - MarketBeat
TIAA Trust National Association Sells 10,325 Shares of AbbVie Inc. $ABBV - MarketBeat
Accuvest Global Advisors Sells 1,690 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Great Lakes Retirement Inc. - MarketBeat
Why AbbVie Stock Flopped on Friday - AOL.com
AbbVie (ABBV) Surpasses Q3 Expectations with Strong Revenue Grow - GuruFocus
ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat - MSN
Longbow Finance SA Purchases 37,626 Shares of AbbVie Inc. $ABBV - MarketBeat
Lifeworks Advisors LLC Purchases 1,575 Shares of AbbVie Inc. $ABBV - MarketBeat
Crescent Sterling Ltd. Has $2.90 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Center for Financial Planning Inc. Boosts Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Syverson Strege & Co - MarketBeat
Leeward Financial Partners LLC Buys New Stake in AbbVie Inc. $ABBV - MarketBeat
Haven Private LLC Takes Position in AbbVie Inc. $ABBV - MarketBeat
Tax Court allows ordinary deduction of termination fees - Journal of Accountancy
Assetmark Inc. Decreases Position in AbbVie Inc. $ABBV - MarketBeat
Will AbbVie Inc. (Common Stock) (4AB0) stock test record highs in 2025Long Setup & Low Risk High Win Rate Picks - newser.com
AbbVie Inc. (NYSE:ABBV) to Issue Quarterly Dividend of $1.73 - MarketBeat
AbbVie (ABBV) Margin Compression Reinforces Investor Caution After $14.5 Billion One-Off Loss - Yahoo Finance
AbbVie (NYSE:ABBV) Updates Q4 2025 Earnings Guidance - MarketBeat
AbbVie Inc. stock underperforms Friday when compared to competitors - MSN
AbbVie (NYSE:ABBV) Stock Price Down 4.4%Should You Sell? - MarketBeat
Five Things To Know About AbbVie’s Q3 Sales And Earnings Report - Citeline News & Insights
Looking Into AbbVie Inc's Recent Short Interest - Fidelity
AbbVie (ABBV) Exceeds Q3 Expectations, Raises 2025 Outlook - GuruFocus
AbbVie Inc. (ABBV) Stock Slides 4.45% as Q3 EPS Plunges 88%, Despite 9% Revenue Growth and Strong Immunology Sales - CoinCentral
AbbVie (ABBV) Reports Strong Linzess Sales in Q3 - GuruFocus
Ironwood surges 28% as beneficiary of partner AbbVie's Linzess Q3 sales (IRWD:NASDAQ) - Seeking Alpha
AbbVie raises 2025 EPS guidance and signals strong pipeline milestones into 2026 - MSN
AbbVie (NYSE:ABBV) Releases Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
AbbVie Q3 Earnings & Sales Beat, 2025 EPS Outlook Raised - sharewise.com
AbbVie Inc (ABBV) Q3 2025 Earnings Call Highlights: Strong Financial Performance Amidst Humira ... - Yahoo Finance
AbbVie Inc (ABBV) Q3 2025 Earnings Call Highlights: Strong Financial Performance Amidst Humira Challenges - GuruFocus
AbbVie raises full-year forecast, Newell Brands stock plunges - Yahoo Finance
AbbVie (ABBV) Boosts Quarterly Dividend by 5.5% - GuruFocus
AbbVie Inc. Announces Intangible Asset Impairment for the Third Quarter Ended September 30, 2025 - MarketScreener
Research Alert: CFRA Keeps Buy Rating On Shares Of Abbvie Inc. - 富途牛牛
Why AbbVie (ABBV) Shares Are Falling Today - Yahoo Finance
AbbVie (ABBV) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - sharewise.com
AbbVie Inc (ABBV) Q3 Earnings: Adjusted EPS of $1.86 Surpasses E - GuruFocus
AbbVie says Trump pressing for larger Medicare drug price cuts - Reuters
AbbVie near 1-month low after earnings report 📉 - XTB.com
AbbVie raises outlook on strong sales of mainstay drugs - Crain's Chicago Business
AbbVie Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Abbvie Inc (ABBV) 財務データ
収益
当期純利益
現金流量
EPS
0.10%
0.96%
大文字化:
|
ボリューム (24 時間):